Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kitze

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Neurology|May 1, 1996
Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathyB Kitze, K Usuku, S Izumo, et al.
Journal of Neuroimmunology|June 1, 1997
Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis)Y Yamano, B Kitze, S Yashiki, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1997
Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disorders among Japanese patientsK Kubo, T Fujiyoshi, M M Yokoyama, et al.
Journal of Neuroimmunology|February 1, 1996
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisP Rieckmann, F Weber, A Günther, et al.
Neurology|December 1, 1994
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapseP Rieckmann, S Martin, I Weichselbraun, et al.
Journal of Neuroimmunology|November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1bJ Brettschneider, D Ecker, A Bitsch, et al.
European Journal of Neurology|June 14, 2008
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patientsA Millonig, A Dressel, D Bahner, et al.
Acta Neurologica Scandinavica|November 6, 2004
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosisA Bitsch, D Bahner, C Wachter, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Neurology|May 1, 1996
Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathyB Kitze, K Usuku, S Izumo, et al.
Journal of Neuroimmunology|June 1, 1997
Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis)Y Yamano, B Kitze, S Yashiki, et al.
Clinical and Diagnostic Laboratory Immunology|March 1, 1997
Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disorders among Japanese patientsK Kubo, T Fujiyoshi, M M Yokoyama, et al.
Journal of Neuroimmunology|February 1, 1996
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisP Rieckmann, F Weber, A Günther, et al.
Neurology|December 1, 1994
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapseP Rieckmann, S Martin, I Weichselbraun, et al.
Journal of Neuroimmunology|November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1bJ Brettschneider, D Ecker, A Bitsch, et al.
European Journal of Neurology|June 14, 2008
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patientsA Millonig, A Dressel, D Bahner, et al.
Acta Neurologica Scandinavica|November 6, 2004
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosisA Bitsch, D Bahner, C Wachter, et al.
Pageof 3